Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andreas Josting

Phase 2 Study of BACOPP (Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone) in Older Patients With Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

Blood

English

Related publications

The Prognostic Impact of Variant Histology in Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie

Oncology

2016

English

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

British Journal of Haematology

Hematology

2015

English

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma

English

A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone (LR-CD) for Untreated Low-Grade Non-Hodgkin Lymphoma Requiring Therapy

American Journal of Hematology

Hematology

2017

English

Pembrolizumab Monotherapy in Patients With Primary Refractory Classical Hodgkin Lymphoma: Subgroup Analysis of the Phase 2 Keynote-087 Study

Hematological Oncology

English

Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide, Vincristine/Vindesine, and Prednisone in Patients With Aggressive T-Cell Lymphoma: Preliminary Results of Aphase Ii Study

Hematological Oncology

English

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus

Hematological Oncology

English

Mortality Rates Remain Increased in Young Patients With Classical Hodgkin Lymphoma Even After Years in Remission: Results From a Nordic Lymphoma Group Study

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andreas Josting

Phase 2 Study of BACOPP (Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone) in Older Patients With Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

Related publications

The Prognostic Impact of Variant Histology in Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma

A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone (LR-CD) for Untreated Low-Grade Non-Hodgkin Lymphoma Requiring Therapy

Pembrolizumab Monotherapy in Patients With Primary Refractory Classical Hodgkin Lymphoma: Subgroup Analysis of the Phase 2 Keynote-087 Study

Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide, Vincristine/Vindesine, and Prednisone in Patients With Aggressive T-Cell Lymphoma: Preliminary Results of Aphase Ii Study

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus

Mortality Rates Remain Increased in Young Patients With Classical Hodgkin Lymphoma Even After Years in Remission: Results From a Nordic Lymphoma Group Study